Methodology for computing the burden of disease of adverse events following immunization-Reference-Cited by-同舟云学术

Methodology for computing the burden of disease of adverse events following immunization

Published:2018-03-24 Issue:7 Volume:27 Page:724-730
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

McDonald Scott A.¹^ORCID,Nijsten Danielle¹,Bollaerts Kaatje²,Bauwens Jorgen³⁴,Praet Nicolas⁵,van der Sande Marianne¹⁶,Bauchau Vincent⁵,de Smedt Tom²,Sturkenboom Miriam²⁷,Hahné Susan¹

Affiliation:

1. National Institute for Public Health and the Environment (RIVM); Bilthoven The Netherlands

2. P95 Pharmacovigilance and Epidemiology Services; Leuven Belgium

3. University of Basel Children's Hospital; Basel Switzerland

4. Brighton Collaboration Foundation; Basel Switzerland

5. GlaxoSmithKline Vaccines; Rixenart Belgium

6. Department Public Health; Institute of Tropical Medicine; Antwerp Belgium

7. VACCINE.GRID Foundation; Basel Switzerland

Funder

Innovative Medicines Initiative Joint Undertaking

European Union's Seventh Framework Programme

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference35 articles.

1. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases;Omer;N Engl J Med,2009

2. World Health Organization (WHO) Causality assessment of an adverse event following immunization (AEFI) http://apps.who.int/iris/bitstream/10665/80670/1/9789241505338_eng.pdf

3. Quantifying the burden of disease: the technical basis for disability-adjusted life years;Murray;Bull World Health Organ,1994

4. MCV vaccination in the presence of vaccine-associated Guillain-Barre syndrome risk: a decision analysis approach;Cho;Vaccine,2010

5. The benefits and risks of bacille Calmette-Guerin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model;Clark;BMC Pediatr,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data;Vaccine;2024-02

2. Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis;American Journal of Epidemiology;2023-03-14

3. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella;PharmacoEconomics;2023-02-21

4. Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries;Human Vaccines & Immunotherapeutics;2023-01-02

5. Comprehensive Measurement of the Burden of Disease due to Adverse Events: A New Analysis of the Cross-Sectional Patient Safety Incident Inquiry;Journal of Korean Medical Science;2023